These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: A comparative study of metoprolol and methyldopa in the treatment of hypertension.
    Author: Karachalios GN.
    Journal: Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):476-8. PubMed ID: 6629553.
    Abstract:
    The efficacy of metoprolol, a new cardioselective beta-blocking drug, was compared with that of methyldopa in patients with mild to moderate essential hypertension in a long-term study. A total of 25 patients received metoprolol in a maximum dose of 200 mg once daily; 30 patients received 500 mg methyldopa twice a day. Both groups of hypertensive patients had similar blood pressure upon entering the study (methyldopa: 182/110 mmHg; metoprolol: 180/110 mmHg). Two years after continuing therapy the blood pressures were similar (methyldopa: 142/90 mmHg; metoprolol: 145/90 mmHg). The great difference between the two drugs was the incidence and severity of side effects, here metoprolol offered a definite advantage.
    [Abstract] [Full Text] [Related] [New Search]